{"url":"https://lda.senate.gov/api/v1/filings/f77ff540-32d3-4b2b-bf38-6a930fc75da9/","filing_uuid":"f77ff540-32d3-4b2b-bf38-6a930fc75da9","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2021,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/f77ff540-32d3-4b2b-bf38-6a930fc75da9/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Cynthia Broydrick","dt_posted":"2021-10-19T06:35:15.933000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1150 Connecticut Ave. NW #615","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":7268,"url":"https://lda.senate.gov/api/v1/registrants/7268/","house_registrant_id":32405,"name":"BROYDRICK & ASSOCIATES","description":"Government relations and lobbying.","address_1":"101 Constitution Avenue NW","address_2":"Suite 825 East","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CYNTHIA BROYDRICK","contact_telephone":"+1 202-637-0637","dt_updated":"2026-01-28T18:44:44.787248-05:00"},"client":{"id":110510,"url":"https://lda.senate.gov/api/v1/clients/110510/","client_id":2512,"name":"EXELA PHARMA SCIENCES","general_description":"Injectable and ophthalmic pharmaceutical products.","client_government_entity":false,"client_self_select":null,"state":"NC","state_display":"North Carolina","country":"US","country_display":"United States of America","ppb_state":"NC","ppb_state_display":"North Carolina","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-01-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Drug shortages and FDA approval, USTR acceptance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":39821,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":"B","last_name":"BROYDRICK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}